click below
click below
Normal Size Small Size show me how
CNS 5
| Pharmacologic Category | Generic | Brand | Classification | Indication | Key side effects | Boxed warnings | Other notes |
|---|---|---|---|---|---|---|---|
| Antianxiety agent | buspirone (PO) | Buspar | n/a | Anxiety | dizziness, drowsiness, nausea | n/a | do not use with MAOI |
| Benzodiazepine | alprazolam (PO) | Xanax | CS-IV | Anxiety | daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia | risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions | parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | clonazepam (PO) | Klonopin | CS-IV | Anxiety, seizure disorders | daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia | risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions | parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | diazepam (PO, IV) | Valium | CS-IV | Anxiety, seizure disorders, acute alcohol withdrawal | daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia | risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions | parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | lorazepam (PO, IV) | Ativan | CS-IV | Anxiety, seizure disorders, acute alcohol withdrawal | daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia | risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions | parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | midazolam (IV, IM) | Versed | CS-IV | Anesthesia, sedation | hypotension, apnea, bradypnea | risk of profound sedation, respiratory depression, coma/death with opioids or used for sedation in noncritical places; risk of abuse,misuse,addiction; risk of dependence/withdrawal reactions; dose must be individualized; never by rapid inject in neonat | n/a |
| Hypnotic | zolpidem (PO) | PO: Ambien, Ambien CR SL: Edluar | CS-IV | Insomnia | decreased ability to function the next morning, somnolence, headache, dizziness, xerostomia, anterograde amnesia, parasomnias | serious injuries, including death, have occurred because of complex sleep behaviors (i.e., sleepwalking, sleep driving, and engaging in other activities while not fully awake); CI in patients with history of complex sleep behaviors | n/a |
| Sleep aid | melatonin (PO) | n/a | OTC | Insomnia, jet lag | drowsiness, daytime somnolence | n/a | n/a |
| Sedative, general anesthetic | propofol (IV) | Diprivan | n/a | Sedation for mechanical ventilation, procedural anesthesia, status epilepticus | bradycardia, hypotension, hypertriglyceridemia, propofol-related infusion syndrome (rare) | n/a | formulated as a 10% lipid emulsion containing 1.1 kcal/mL |
| Alpha2 agonist, sedative | dexmedetomidine (IV) | Precedex | n/a | Sedation for mechanical ventilation or procedures | bradycardia, hypotension | n/a | tolerance and tachyphylaxis may occur if used longer than 24 hours |